ClearPoint Neuro CLPT Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about ClearPoint Neuro's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ClearPoint Neuro's additional paid-in capital?
- ClearPoint Neuro (CLPT) reported additional paid-in capital of $239.47M in Q1 2026.
- How has ClearPoint Neuro's additional paid-in capital changed year-over-year?
- ClearPoint Neuro's additional paid-in capital increased by 10.3% year-over-year, from $217.1M to $239.47M.
- What is the long-term trend for ClearPoint Neuro's additional paid-in capital?
- Over 5 years (2020 to 2025), ClearPoint Neuro's additional paid-in capital has grown at a 14.4% compound annual growth rate (CAGR), from $121.73M to $239M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.